NEWARK – Acting Attorney General Andrew J. Bruck today announced that the State Board of Medical Examiners (“the Board”) has temporarily suspended the license of an Essex County physician amid allegations that he has been traveling to dozens of offices in New Jersey and neighboring states, performing invasive aesthetic procedures with inadequate formal training and little regard for the health and safety of his patients.
Dr. Muhammad A. Mirza, a board-certified internist from Cedar Grove, advertises and performs a variety of costly and invasive cosmetic enhancement services through his “Mirza Aesthetics” practice, which he operates primarily from rental spaces in New Jersey, New York, Connecticut, and Pennsylvania.
Traveling from office to office, carrying medical products in duffle bags, Mirza allegedly sees up to 30 patients daily in makeshift spaces with substandard protocols for medical recordkeeping, patient follow-up, and storage of medical supplies, including products that require refrigeration and strict temperature control.
In a Verified Complaint filed with the Board, the State alleges that Mirza’s practice of aesthetic medicine grossly deviates from accepted standards of medical care because he performs procedures in a manner that could cause bodily harm, lacks formal medical training and an adequate knowledge of aesthetic medicine, performs procedures in inappropriate office settings, and fails to properly store medical supplies or maintain records.
Mirza’s improper use of certain dermal fillers for off-label purposes - including non-surgical penile and breast enhancement procedures - poses a clear and imminent danger to the public, the State alleged in the Verified Complaint.
In one instance, Mirza’s use of an injectable dermal filler in a nonsurgical penile enhancement procedure allegedly caused permanent harm to a patient who suffered complications that required his hospitalization, where he underwent two emergency surgical interventions. When consulted by an emergency room physician regarding his treatment of the patient, Mirza allegedly failed to accurately disclose the exact filler he injected into the patient’s penis, further complicating the patient’s post-procedure emergency care.
“Patients who seek cosmetic procedures are entitled to safe and appropriate care by properly trained professionals who put their health and safety above all else,” said Acting Attorney General Bruck. “We will not allow doctors to take advantage of patients’ desires to look and feel better about themselves by subjecting them to medically inappropriate procedures that expose them to grave harm and permanent disfigurement.”
Under an Interim Consent Order with the Board, Mirza, who denies the allegations against him, agreed to the temporary suspension of his license until his case is heard by an Administrative Law Judge and until further action of the Board.
In addition to temporarily suspending Mirza’s license to practice medicine in New Jersey, the Interim Consent Order prohibits him from treating New Jersey patients in any other location where he is licensed to practice, including New York, Pennsylvania, and Connecticut.
“Doctors who flout accepted standards in the practice of aesthetic medicine, as alleged in this case, place their patients at risk and enrich themselves at the expense of public health and safety,” said Sean P. Neafsey, Acting Director of the Division of Consumer Affairs. “The temporary measures announced today make full use of the Board’s authority to ensure New Jersey residents are adequately protected while this case moves forward.”
The State alleges that Mirza engaged in repeated acts of negligence, professional misconduct, gross negligence and endangerment, and other professional standards violations in conduct that also includes:
- improper off-label use of an injectable dermal filler for aesthetic procedures close to patients’ eyes, which, if done incorrectly, can lead to loss of vision or permanent blindness;
- improper off-label use of an injectable dermal filler for breast enhancement, which can obfuscate patients’ mammogram results; and
- using a certain injectable dermal filler without performing a skin allergy test on patients prior to injection, as required, which can cause patients to suffer acute episodes of hypotension, breathing difficulties, and other allergic reactions.
The Enforcement Bureau of the Division of Consumer Affairs (“EB”) opened an investigation into Mirza and Mirza Aesthetics in April 2021, following the Board’s receipt of numerous consumer complaints about the doctor and his practice of aesthetic medicine.
Patient complaints include allegations that Mirza:
- failed to wear a mask or medical surgical gloves while performing procedures;
- used high pressure sales tactics;
- would not disclose what products he was using or show the product's packaging to them;
- caused physical complications like a lump and seizure;
- failed to respond to post-procedure complaints and/or requests for records; and
- performed aesthetic procedures in an area described as a “small storage closet” and “closet area with a bench.”
EB investigators conducted a subsequent inspection of Mirza’s office in Summit, NJ which revealed, among other things, that:
- the medical office consisted of one large room with a curtain used as a divider between the waiting room/receptionist area and the patient examination/treatment area;
- the examination/treatment area had only chairs and a fold-away table, with no medical examination table; and • Mirza’s supply of injectable fillers was stored in “duffle bags,” and no medical storage refrigerators were observed on the premises.
Investigators with the Enforcement Bureau, within the Division of Consumer Affairs, conducted the investigation into this matter.
Deputy Attorneys General Michael Antenucci and Daniel Hewitt, of the Professional Boards Prosecution Section in the Division of Law’s Affirmative Civil Enforcement Practice Group, are representing the State in this matter.
Patients who believe that they have been treated by a licensed health care professional in an inappropriate manner can file an online complaint with the State Division of Consumer Affairs by visiting its website or by calling 1-800-242-5846 (toll free within New Jersey) or 973-504-6200.
The mission of the Division of Consumer Affairs, within the Department of Law and Public Safety, is to protect the public from fraud, deceit, misrepresentation, and professional misconduct in the sale of goods and services in New Jersey through education, advocacy, regulation, and enforcement. The Division pursues its mission through its 51 professional and occupational boards that oversee 720,000 licensees in the state, its Regulated Business section that oversees 60,000 NJ registered businesses, as well as through its Office of Consumer Protection, Bureau of Securities, Charities Registration section, Office of Weights and Measures, and Legalized Games of Chance section.
###
